Tailored Treatment to Enhance Risk Perception in Sleep Apnea
Tailored Treatment to Enhance Risk Perception in Sleep Apnea.
Sponsor: National Heart, Lung, and Blood Institute (NHLBI)
A NA clinical study on Obstructive Sleep Apnea (OSA), this trial is completed. The trial is conducted by National Heart, Lung, and Blood Institute (NHLBI) and has accumulated 8 data snapshots since 2014. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
8 versions recorded-
Sep 2024 — Present [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Sep 2021 — Jul 2024 [monthly]
Completed NA
Status: Active Not Recruiting → Completed
-
Jan 2021 — Sep 2021 [monthly]
Active Not Recruiting NA
-
Oct 2020 — Jan 2021 [monthly]
Active Not Recruiting NA
Status: Unknown Status → Active Not Recruiting
▶ Show 3 earlier versions
-
May 2019 — Oct 2020 [monthly]
Unknown Status NA
Status: Recruiting → Unknown Status
-
Jun 2018 — May 2019 [monthly]
Recruiting NA
-
Jan 2017 — Jun 2018 [monthly]
Recruiting NA
First recorded
Oct 2014
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- National Heart, Lung, and Blood Institute (NHLBI)
- National Institutes of Health (NIH)
- National Jewish Health
For direct contact, visit the study record on ClinicalTrials.gov .